PFM Health Sciences LP 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,306,671 4.800% | -2,174,093 (-33.55%) | Filing |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 6,480,764 7.300% | 2,020,981 (+45.32%) | Filing |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,459,783 7.300% | 367,474 (+8.98%) | Filing |
| 2022-02-14 12:35 pm Unchanged | 2021-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,092,309 6.800% | 0 (Unchanged) | Filing |
| 2021-08-06 5:04 pm Purchase | 2021-07-27 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,092,309 7.200% | 4,092,309 (New Position) | Filing |